BRPI0413332A - dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos - Google Patents

dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos

Info

Publication number
BRPI0413332A
BRPI0413332A BRPI0413332-3A BRPI0413332A BRPI0413332A BR PI0413332 A BRPI0413332 A BR PI0413332A BR PI0413332 A BRPI0413332 A BR PI0413332A BR PI0413332 A BRPI0413332 A BR PI0413332A
Authority
BR
Brazil
Prior art keywords
markers
well
body fluid
fluid sample
disease states
Prior art date
Application number
BRPI0413332-3A
Other languages
English (en)
Inventor
Harald Mischak
Stefan Wittke
Thorsten Kaiser
Original Assignee
Mosaiques Diagnostics & Therap
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mosaiques Diagnostics & Therap filed Critical Mosaiques Diagnostics & Therap
Publication of BRPI0413332A publication Critical patent/BRPI0413332A/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00Electrophoretic profiling, e.g. for proteome analysis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

"DISPOSITIVO E PROCESSO PARA AVALIAçãO QUANTITATIVA DOS POLIPETìDEOS CONTIDOS EM UMA AMOSTRA DE FLUIDO CORPORAL BEM COMO MARCADORES PARA IDENTIFICAçãO DE ESTADOS PATOLóGICOS". A presente invenção refere-se a dispositivos e processos para a avaliação quantitativa dos polipeptídeos contidos em uma amostra de fluido corporal e comparação com valores de referência armazenados em um banco de dados bem como marcadores para identificação de estados patológicos que são descritos. Os polipeptídeos são comparados com valores de referência armazenados em um banco de dados. Esses valores de referência são armazenados como conjuntos de dados de polipeptídeos relevantes ao estado, que abrangem respectivamente ao menos uma indicação sobre a probabilidade para a ocorrência ou a concentração dos polipeptídeos para um estado patológico em amostras de indivíduos testados saudáveis e doentes.
BRPI0413332-3A 2003-09-06 2004-09-03 dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos BRPI0413332A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10341193A DE10341193A1 (de) 2003-09-06 2003-09-06 Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen
PCT/EP2004/009833 WO2005024409A1 (de) 2003-09-06 2004-09-03 Vorrichtung und verfahren zur quantitativen auswertung der in einer körperflüssigkeitsprobe enthaltenen polypeptide sowie marker zur erkennung von pathologischen zuständen

Publications (1)

Publication Number Publication Date
BRPI0413332A true BRPI0413332A (pt) 2006-10-10

Family

ID=34223428

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413332-3A BRPI0413332A (pt) 2003-09-06 2004-09-03 dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos

Country Status (11)

Country Link
US (1) US20070082402A1 (pt)
EP (1) EP1660880A1 (pt)
JP (1) JP4765078B2 (pt)
KR (1) KR20060132558A (pt)
CN (1) CN1846133A (pt)
AU (1) AU2004270861B9 (pt)
BR (1) BRPI0413332A (pt)
CA (1) CA2537588A1 (pt)
DE (1) DE10341193A1 (pt)
RU (1) RU2425374C2 (pt)
WO (1) WO2005024409A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
US20060286602A1 (en) * 2004-05-10 2006-12-21 Harald Mischak Method and markers for the diagnosis of renal diseases
CA2604033A1 (en) * 2005-04-06 2006-10-12 Mosaiques Diagnostics And Therapeutics Ag Polypeptide markers for the diagnosis of alzheimer's disease
EP1866648A2 (de) * 2005-04-07 2007-12-19 mosaiques diagnostics and therapeutics AG Polypeptidmarker zur diagnose von prostatakrebs
JP5155857B2 (ja) * 2005-06-29 2013-03-06 モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト 移植腎の拒絶の早期認識のためのポリペプチドマーカー
ATE519116T1 (de) * 2007-03-07 2011-08-15 Mosaiques Diagnostics & Therap Verfahren zur normierung der konzentration von analyten in einer urinprobe
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
CA2701571A1 (en) * 2007-10-09 2009-04-16 Mosaiques Diagnostics And Therapeutics Ag Polypeptide markers for the diagnosis of prostate cancer
EP2051078A1 (de) * 2007-10-19 2009-04-22 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Diabetes Mellitus
EP2255203A2 (de) * 2008-03-19 2010-12-01 Mosaiques Diagnostics And Therapeutics AG Verfahren und marker zur diagnose von tubulären nierenschäden und -erkrankungen
US20110214990A1 (en) * 2008-09-17 2011-09-08 Mosaiques Diagnostics And Therapeutics Ag Kidney cell carcinoma
CN117169534A (zh) 2019-08-05 2023-12-05 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT922226E (pt) * 1996-08-13 2003-07-31 Biovision Ag Processo para a avaliacao do estado de um organismo por meio de medicao de peptideos
DE19702774C2 (de) * 1997-01-27 2002-04-18 Pe Diagnostik Gmbh Verfahren zur Ermittlung von Daten für eine Wissensbank und ihre Verwendung bei der Analyse von Gleichgewichtssituationen der in Wechselwirkung befindlichen Mineralien und Spurenelemente in Körperflüssigkeiten
DE19919982C2 (de) * 1999-04-30 2001-06-28 Pe Diagnostik Gmbh Verfahren zur Ermittlung osteoporotischer Prozesse
DE10021737C2 (de) * 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
DE10021597A1 (de) * 2000-05-04 2001-11-15 Forschungszentrum Juelich Gmbh Verfahren zur Optimierung der Parameter eines Trennungsverfahrens für Stoffgemische
US20020087273A1 (en) * 2001-01-04 2002-07-04 Anderson Norman G. Reference database
WO2003019193A1 (en) * 2001-08-30 2003-03-06 Ciphergen Biosystems, Inc. Method of diagnosing nephrotic syndrome
KR20050004781A (ko) * 2002-02-19 2005-01-12 게놈 인스티튜트 오브 싱가포르 등전 집중 장치

Also Published As

Publication number Publication date
JP2007504466A (ja) 2007-03-01
AU2004270861A1 (en) 2005-03-17
RU2425374C2 (ru) 2011-07-27
JP4765078B2 (ja) 2011-09-07
WO2005024409A1 (de) 2005-03-17
KR20060132558A (ko) 2006-12-21
CA2537588A1 (en) 2005-03-17
US20070082402A1 (en) 2007-04-12
DE10341193A1 (de) 2005-03-31
RU2006111095A (ru) 2006-08-10
AU2004270861B9 (en) 2011-01-27
AU2004270861B2 (en) 2010-11-18
CN1846133A (zh) 2006-10-11
EP1660880A1 (de) 2006-05-31

Similar Documents

Publication Publication Date Title
BRPI0413332A (pt) dispositivo e processo para avaliação quantitativa dos polipetìdeos contidos em uma amostra de fluido corporal bem como marcadores para identificação de estados patológicos
ES2871823T3 (es) Biomarcadores relacionados con la función renal y métodos para utilizarlos
ATE411525T1 (de) Nachweis einer histonmodifikation in zellfreien nukleosomen
Banne et al. Reduced level of serum thiols in patients with a diagnosis of active disease
DE60233949D1 (de) Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
BRPI0509978A (pt) uso de padrão proteÈmico de plasma para diagnóstico, classificação, previsão de resposta à terapia e comportamento clìnico, estratificação de terapia, e monitoramento de doença em malignidades hematológicas
JP5330381B2 (ja) 酸化還元電位(orp)を測定及び使用する方法
CY1116147T1 (el) Μεθοδος για την ταυτοποιηση ενος υποκειμενου που κινδυνευει να παρουσιασει καρδιακη ανεπαρκεια, μεσω του προσδιορισμου του επιπεδου γαλεκτινης-3 ή θρομβοσπονδινης-2
BRPI0411695A (pt) dispositivos e métodos relacionados a biossensores eletroquìmicos
BRPI0520012A2 (pt) identificação de marcadores moleculares de diagnóstico para endometriose em linfócitos do sangue
JP2007523324A5 (pt)
ATE406834T1 (de) System zur überwachung der konzentration von analyten in körperflüssigkeiten
BRPI0516674A (pt) método de análise de mal de alzheimer e reagente de diagnóstico
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
BR0115715A (pt) Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
CY1108182T1 (el) Μεσα εντοπισμου του παθολογικου μετασχηματισμου της πρωτεϊνης app και εφαρμογες τους
TW200613734A (en) Detection and identification of peptide and protein modifications
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
ES2549860T3 (es) Diagnóstico y pronóstico de estados patológicos relacionados con la dipepitidil peptidasa
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
BRPI0512948A (pt) biomarcadores de mal de alzheimer
Seidensticker et al. Sexing young snowy owls
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
BR0102781A (pt) Processos para identificação de combinações de entidades como terapêuticos
WO2001020533A3 (en) Creation of a database of biochemical data and methods of use

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.